Affiliation:
1. NETES Institute of Pharmaceutical Science, India
2. FPS, Assam Downtown University, India
3. Royal School of Pharmacy, The Assam Royal Global University, India
Abstract
The pandemic, which is brought about by the SARS CoV-2 infection, has inundated the entire world and obliterated the economies of numerous nations. Hence, looking for treatment and prophylaxis of COVID-19, Quercetin, which is a flavonoid gotten from plants and different sources like grapes, onion, tomatoes, apple, and so forth and has various properties like calming property, cardioprotective, and neuroprotective properties, is inspected for its antiviral properties, so it tends to be considered as one of the adjuvant medicines alongside the pharmacological medicines like Remdesivir and plasma treatment. A survey of the antiviral property of Quercetin from distributed articles proposes that Quercetin has a solid antiviral movement towards SARS C0V-2 and other upper respiratory tract infections. It can be securely and financially used to battle COVID-19. For high-hazard populaces, this medication can be a brilliant decision of treatment. Here the authors give proof to the utilization of Quercetin in relationship with pharmacological treatments like Remdesivir or improving plasma treatment.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献